Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T, Ogawa T, Takahashi S, Okami K, Fujii T, Tanaka K, Iwae S, Ota I, Ueda T, Monden N, Matsuura K, Kojima H, Ueda S, Sasaki K, Fujimoto Y, Hasegawa Y, Beppu T, Nishimori H, Hirano S, Naka Y, Matsushima Y, Fujii M, Tahara M. Yokota T, et al. Among authors: hasegawa y. BMC Cancer. 2017 May 5;17(1):314. doi: 10.1186/s12885-017-3295-4. BMC Cancer. 2017. PMID: 28476132 Free PMC article. Clinical Trial.
Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer.
Tahara M, Minami H, Hasegawa Y, Tomita K, Watanabe A, Nibu K, Fujii M, Onozawa Y, Kurono Y, Sagae D, Seriu T, Tsukuda M. Tahara M, et al. Among authors: hasegawa y. Cancer Chemother Pharmacol. 2011 Sep;68(3):769-76. doi: 10.1007/s00280-010-1550-3. Epub 2010 Dec 24. Cancer Chemother Pharmacol. 2011. PMID: 21181475 Clinical Trial.
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Tahara M, Kiyota N, Yokota T, Hasegawa Y, Muro K, Takahashi S, Onoe T, Homma A, Taguchi J, Suzuki M, Minato K, Yane K, Ueda S, Hara H, Saijo K, Yamanaka T. Tahara M, et al. Among authors: hasegawa y. Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040. Ann Oncol. 2018. PMID: 29408977 Free article. Clinical Trial.
[Retropharyngeal node metastasis in cancer of the oropharynx and hypopharynx: analysis of retropharyngeal node dissection regarding preoperative radiographic diagnosis].
Okumura K, Fujimoto Y, Hasegawa Y, Matsuura H, Nakayama B, Komura T, Ogawa T, Terada A, Matsuzuka T. Okumura K, et al. Among authors: hasegawa y. Nihon Jibiinkoka Gakkai Kaiho. 1998 May;101(5):573-7. doi: 10.3950/jibiinkoka.101.5_573. Nihon Jibiinkoka Gakkai Kaiho. 1998. PMID: 9642997 Clinical Trial. Japanese.
4,797 results